Pharmacokinetic modelling for the simultaneous assessment of perfusion and 18F-flutemetamol uptake in cerebral amyloid angiopathy using a reduced PET-MR acquisition time: Proof of concept

MLA

Giorgos Papanastasiou, et al. “Pharmacokinetic Modelling for the Simultaneous Assessment of Perfusion and 18F-Flutemetamol Uptake in Cerebral Amyloid Angiopathy Using a Reduced PET-MR Acquisition Time: Proof of Concept.” NeuroImage, vol. 225, no. 117482-, Jan. 2021. EBSCOhost, https://doi.org/10.1016/j.neuroimage.2020.117482.

APA

Giorgos Papanastasiou, Mark A. Rodrigues, Chengjia Wang, Kerstin Heurling, Christophe Lucatelli, Rustam Al-Shahi Salman, Joanna M. Wardlaw, Edwin J.R. van Beek, & Gerard Thompson. (2021). Pharmacokinetic modelling for the simultaneous assessment of perfusion and 18F-flutemetamol uptake in cerebral amyloid angiopathy using a reduced PET-MR acquisition time: Proof of concept. NeuroImage, 225(117482-). https://doi.org/10.1016/j.neuroimage.2020.117482

Chicago

Giorgos Papanastasiou, Mark A. Rodrigues, Chengjia Wang, Kerstin Heurling, Christophe Lucatelli, Rustam Al-Shahi Salman, Joanna M. Wardlaw, Edwin J.R. van Beek, and Gerard Thompson. 2021. “Pharmacokinetic Modelling for the Simultaneous Assessment of Perfusion and 18F-Flutemetamol Uptake in Cerebral Amyloid Angiopathy Using a Reduced PET-MR Acquisition Time: Proof of Concept.” NeuroImage 225 (117482-). doi:10.1016/j.neuroimage.2020.117482.